Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Cancer. 2017 Aug 17;123(23):4617–4630. doi: 10.1002/cncr.30892

Figure 2.

Figure 2

Geometric mean plasma concentrations for filanesib as a function of time following filanesib administration as a 1-hour infusion on Day 1 and Day 2 (vertical gray lines) of Cycle 1 (closed circles) and Cycle 2 (open boxes). Plots are shown for doses of 1, 1.25, 1.5, 1.75, 2, or 2.25 mg/m2/day. Error bars represent ± one geometric standard deviation.